Bohan Wei
Vice President of Corporate Development
Replay available
Palvella Therapeutics, Inc. (NASDAQ: PVLA) Q2 2025 earnings conference call, held 2025-08-14. Replay captured from the company's public earnings webcast.

Vice President of Corporate Development
Chief Executive Officer
Chief Scientific Officer
Chief Financial Officer
Analyst at TD Cohen
Analyst at Canaccord Genuity
Analyst at Stiefel
Analyst at Truist
Watch the replay and follow the connected company analysis, news, and investor updates for Palvella Therapeutics, Inc..
WEBVTT 00:00:00.031 -- 00:00:05.479 Good day, and thank you for standing by. Welcome to the Palvela Second Quarter 2025 Financial 00:00:05.479 -- 00:00:07.903 Results and Corporate Update Conference Call. 00:00:07.903 -- 00:00:10.867 At this time, all participants are in a listen-only mode. 00:00:10.867 -- 00:00:14.192 After the speaker's presentation, there will be a question and answer session. 00:00:14.192 -- 00:00:18.238 To ask a question during the session, you will need to press star 11 on your telephone. 00:00:18.238 -- 00:00:21.783 You will then hear an automated message advising that your hand is raised. 00:00:21.783 -- 00:00:24.948 To withdraw your question, please press star 11 again. 00:00:24.948 -- 00:00:27.993 Please be advised that today's conference is being recorded. 00:00:27.993 -- 00:00:32.299 I would now like to hand the conference over to your speaker today, Bohan Wei, Vice President 00:00:32.299 -- 00:00:35.243 of Corporate Development. Please go ahead. 00:00:35.243 -- 00:00:39.229 Thank you, Operator. Good morning, and thank you for joining the Palvela Therapeutics 00:00:39.229 -- 00:00:43.636 Q2 2025 Financial Results and Corporate Update Call. 00:00:43.636 -- 00:00:47.381 As a reminder, our press release detailing today's announcements can be found in the 00:00:47.381 -- 00:00:51.764 Investors section of our website at www.palvelatx.com. 00:00:53.330 -- 00:00:57.558 On today's call, we are joined by Wes Koppenen, our Chief Executive Officer. 00:00:57.558 -- 00:01:04.183 Jeff Martini, our Chief Scientific Officer, and Matt Korenberg, our Chief Financial Officer. 00:01:04.986 -- 00:01:09.090 Before we begin, please note that today's remarks may include forward-looking statements 00:01:09.090 -- 00:01:13.875 regarding our development programs, r...